| pubmed-article:10921554 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10921554 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:10921554 | lifeskim:mentions | umls-concept:C0019046 | lld:lifeskim |
| pubmed-article:10921554 | lifeskim:mentions | umls-concept:C0034632 | lld:lifeskim |
| pubmed-article:10921554 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:10921554 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:10921554 | pubmed:dateCreated | 2000-8-16 | lld:pubmed |
| pubmed-article:10921554 | pubmed:abstractText | To evaluate the safety of oxidized-raffinose cross-linked human hemoglobin, Hemolink, in normal healthy volunteers. | lld:pubmed |
| pubmed-article:10921554 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10921554 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10921554 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10921554 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:10921554 | pubmed:issn | 0090-3493 | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:GreenburgA... | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:BiroG PGP | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:CampbellJ AJA | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:CarmichaelF... | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:PierceC HCH | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:WillanA RAR | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:AliA CAC | lld:pubmed |
| pubmed-article:10921554 | pubmed:author | pubmed-author:LangloisS FSF | lld:pubmed |
| pubmed-article:10921554 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10921554 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:10921554 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10921554 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10921554 | pubmed:pagination | 2283-92 | lld:pubmed |
| pubmed-article:10921554 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:meshHeading | pubmed-meshheading:10921554... | lld:pubmed |
| pubmed-article:10921554 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10921554 | pubmed:articleTitle | A phase I study of oxidized raffinose cross-linked human hemoglobin. | lld:pubmed |
| pubmed-article:10921554 | pubmed:affiliation | Clinical Affairs Division of Hemosol Inc., Toronto, ON, Canada. | lld:pubmed |
| pubmed-article:10921554 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10921554 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10921554 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10921554 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10921554 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10921554 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10921554 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10921554 | lld:pubmed |
